0.476
2.86%
-0.014
Handel nachbörslich:
.50
0.024
+5.04%
Schlusskurs vom Vortag:
$0.49
Offen:
$0.5
24-Stunden-Volumen:
57,961
Relative Volume:
0.54
Marktkapitalisierung:
$1.81M
Einnahmen:
$23.45M
Nettoeinkommen (Verlust:
$-19.98M
KGV:
-0.0266
EPS:
-17.89
Netto-Cashflow:
$-2.65M
1W Leistung:
+1.28%
1M Leistung:
-6.67%
6M Leistung:
-33.47%
1J Leistung:
-27.33%
cbdMD Inc Stock (YCBD) Company Profile
Firmenname
cbdMD Inc
Sektor
Telefon
704-445-5800
Adresse
4521 Sharon Road, Charlotte, NC
Vergleichen Sie YCBD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
YCBD | 0.476 | 1.81M | 23.45M | -19.98M | -2.65M | -17.89 |
ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
cbdMD Inc Aktie (YCBD) Neueste Nachrichten
CbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Barchart
cbdMD Launches THC Seltzers in $4B Market Push with Fast-Acting Technology | YCBD Stock News - StockTitan
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine - Quantisnow
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth - Quantisnow
cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 2.5% – What’s Next? - Defense World
CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement - Quantisnow
YCBD stock touches 52-week low at $0.44 amid market challenges By Investing.com - Investing.com South Africa
YCBD stock touches 52-week low at $0.44 amid market challenges - Investing.com
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products - Quantisnow
CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness - Quantisnow
CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth - Quantisnow
Top Podcasts Partner with cbdMD - cbdMD
cbdMD Joins Forces with Life Time - cbdMD
CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness - Quantisnow
Wegmans to start carrying cbdMD CBD products - Supermarket News
cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 6.1% - Defense World
cbdMD secures trademark, amends agreements - Investing.com India
cbdMD secures trademark, amends agreements By Investing.com - Investing.com Australia
The Future of Hemp: Innovations in Sustainability - cbdMD
CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries - Quantisnow
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American - Yahoo Finance
cbdMD resolves lease obligations, anticipates gain - Investing.com India
cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales - Benzinga
cbdMD, Inc. (AMEX:YCBD) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: cbdMD reports Q3 results with focus on strategic growth - Investing.com Canada
cbdMD revenue falls 15%, but losses trimmed - Green Market Report
cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024 - StockTitan
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now - Benzinga
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results - West Lorne Chronicle
cbdMD (NYSEAMERICAN:YCBD) Shares Up 5% - Defense World
cbdMD updates share count post-note conversions - Investing.com India
cbdMD submits plan to regain NYSE compliance - Investing.com
cbdMD submits plan to regain NYSE compliance By Investing.com - Investing.com Nigeria
cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock - Quantisnow
I Tested cbdMD Gummies—Here’s My Review - Forbes
cbdMD continues to build science despite lack of federal clarity - NutraIngredients-usa.com
cbdMD, Inc. (NYSEAMERICAN:YCBD) Short Interest Down 13.1% in June - Defense World
cbdMD Announces Publication of Human Clinical Trial - Shoreline Beacon
cbdMD Announces Publication of Human Clinical Trial Data - StockTitan
Shop Premium CBD Products for Your Pets - cbdMD
Shop Quality CBD Oil Drops & Tinctures - cbdMD
cbdMD announces notification of noncompliance with NYSE American listing standards - Seeking Alpha
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards - Yahoo Finance
Farm Bill 2024: 3 Stocks That Would Get Smoked if Hemp Ban Passes - InvestorPlace
No Tariffs on Chinese EVs: Musk - The Globe and Mail
cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions - Kirkland Lake Northern News
Finanzdaten der cbdMD Inc-Aktie (YCBD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):